From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
(rad/mCi)
(mGy/MBq)
32P
14
3.8
89Sr
50
13.5
153Sm-EDTMP
6
1.6
186Re-HEDP
3
0.8
188Re-HEDP
2
0.5